Efficacy of Somapacitan in Treatment-Fatigue Adult Patients With Growth Hormone Deficiency Previously Treated With Once-Daily Growth Hormone Injections: A 24-Week Randomized Active-Controlled Trial
Identification and Differentiation of Somapacitan, a Long-Acting Growth Hormone Derivative, and Recombinant Human Growth Hormone in Equine Plasma by LC-HRMS for Doping Control Purpose